ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
Malcikova, J, Tausch, E, Rossi, D, Sutton, L A, Soussi, T, Zenz, T, Kater, A P, Niemann, C U, Gonzalez, D, Davi, F, Gonzalez Diaz, M, Moreno, C, Gaidano, G, Stamatopoulos, K, Rosenquist, R, Stilgenbauer, S, Ghia, P, Pospisilova, S
Published in Leukemia (01.05.2018)
Published in Leukemia (01.05.2018)
Get full text
Journal Article
p53-dependent non-coding RNA networks in chronic lymphocytic leukemia
Blume, C J, Hotz-Wagenblatt, A, Hüllein, J, Sellner, L, Jethwa, A, Stolz, T, Slabicki, M, Lee, K, Sharathchandra, A, Benner, A, Dietrich, S, Oakes, C C, Dreger, P, te Raa, D, Kater, A P, Jauch, A, Merkel, O, Oren, M, Hielscher, T, Zenz, T
Published in Leukemia (01.10.2015)
Published in Leukemia (01.10.2015)
Get full text
Journal Article
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma
Tomska, K, Kurilov, R, Lee, K S, Hüllein, J, Lukas, M, Sellner, L, Walther, T, Wagner, L, Oleś, M, Brors, B, Huber, W, Zenz, T
Published in Scientific reports (13.08.2018)
Published in Scientific reports (13.08.2018)
Get full text
Journal Article
The impact of SF3B1 mutations in CLL on the DNA-damage response
Te Raa, G D, Derks, I A M, Navrkalova, V, Skowronska, A, Moerland, P D, van Laar, J, Oldreive, C, Monsuur, H, Trbusek, M, Malcikova, J, Lodén, M, Geisler, C H, Hüllein, J, Jethwa, A, Zenz, T, Pospisilova, S, Stankovic, T, van Oers, M H J, Kater, A P, Eldering, E
Published in Leukemia (01.05.2015)
Published in Leukemia (01.05.2015)
Get full text
Journal Article
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
POSPISILOVA, S, GONZALEZ, D, HILLMEN, P, OERS, M. Van, GRIBBEN, J, GHIA, P, MONTSERRAT, E, STILGENBAUER, S, ZENZ, T, MALCIKOVA, J, TRBUSEK, M, ROSSI, D, KATER, A. P, CYMBALISTA, F, EICHHORST, B, HALLEK, M, DÖHNER, H
Published in Leukemia (01.07.2012)
Published in Leukemia (01.07.2012)
Get full text
Journal Article
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
Andersson, E I, Pützer, S, Yadav, B, Dufva, O, Khan, S, He, L, Sellner, L, Schrader, A, Crispatzu, G, Oleś, M, Zhang, H, Adnan-Awad, S, Lagström, S, Bellanger, D, Mpindi, J P, Eldfors, S, Pemovska, T, Pietarinen, P, Lauhio, A, Tomska, K, Cuesta-Mateos, C, Faber, E, Koschmieder, S, Brümmendorf, T H, Kytölä, S, Savolainen, E-R, Siitonen, T, Ellonen, P, Kallioniemi, O, Wennerberg, K, Ding, W, Stern, M-H, Huber, W, Anders, S, Tang, J, Aittokallio, T, Zenz, T, Herling, M, Mustjoki, S
Published in Leukemia (01.03.2018)
Published in Leukemia (01.03.2018)
Get full text
Journal Article
IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus
Drennan, S, D'Avola, A, Gao, Y, Weigel, C, Chrysostomou, E, Steele, A J, Zenz, T, Plass, C, Johnson, P W, Williams, A P, Packham, G, Stevenson, F K, Oakes, C C, Forconi, F
Published in Leukemia (01.08.2017)
Published in Leukemia (01.08.2017)
Get full text
Journal Article
Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton
Knudsen, P B, Hanna, B, Ohl, S, Sellner, L, Zenz, T, Döhner, H, Stilgenbauer, S, Larsen, T O, Lichter, P, Seiffert, M
Published in Leukemia (01.06.2014)
Published in Leukemia (01.06.2014)
Get full text
Journal Article
Role of the tumor microenvironment in mature B-cell lymphoid malignancies
Fowler, Nathan H, Cheah, Chan Yoon, Gascoyne, Randy D, Gribben, John, Neelapu, Sattva S, Ghia, Paolo, Bollard, Catherine, Ansell, Stephen, Curran, Michael, Wilson, Wyndham H, O'Brien, Susan, Grant, Cliona, Little, Richard, Zenz, Thorsten, Nastoupil, Loretta J, Dunleavy, Kieron
Published in Haematologica (Roma) (01.05.2016)
Published in Haematologica (Roma) (01.05.2016)
Get full text
Journal Article
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations
ZENZ, T, VOLLMER, D, DENZEL, T, HÄBE, S, MALCIKOVA, J, KUGLIK, P, TRUONG, S, PATTEN, N, WU, L, OSCIER, D, IBBOTSON, R, GARDINER, A, TRBUSEK, M, TRACY, I, LIN, K, PETTITT, A, POSPISILOVA, S, MAYER, J, HALLEK, M, DÖHNER, H, STILGENBAUER, S, SMARDOVA, J, BENNER, A, SOUSSI, T, HELFRICH, H, HEUBERGER, M, HOTH, P, FUGE, M
Published in Leukemia (01.12.2010)
Published in Leukemia (01.12.2010)
Get full text
Journal Article
EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME
Frustaci, A. M., Montillo, M., Rossi, D., Zinzani, P. L., Motta, M., Gaidano, G., Quaresmini, G., Scarfò, L., Pietrasanta, D., Coscia, M., Deodato, M., Zamprogna, G., Cairoli, R., Stüssi, G., Zucca, E., Pileri, S., Zenz, T., Tedeschi, A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN PATIENTS WITH DLBCL. A MULTICENTER, OPEN‐LABEL, PHASE II TRIAL
Stathis, A., Hitz, F., Schär, S., Novak, U., Fischer, N., Mey, U., Gritti, G., Zander, T., Lang, N., Cairoli, A., Zenz, T., Rhyner, G., Mingrone, W., Schmidt, A., Gaidano, G., Hohaus, S., Stern, A. O., Mamot, C., Bruscagin, A., Musilova, J., Hayoz, S., Bertoni, F., Zucca, E., Dirnhofer, S., Ceriani, L., Rossi, D.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IBRUTINIB FOR UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN NEED OF THERAPY
Østenstad, B., Pirosa, M. C., Schär, S., Brodtkorb, M., Wahlin, B. E., Hernberg, M., Pedersen, M., Stathis, A., Zander, T., Novak, U., Zenz, T., Fischer, N., Krasniqi, F., Hitz, F., Jjohansson, A., Lofgren, D., Meyer, P., Bjørnevik, A. T., Hayoz, S., Scheibe, B., Steiner, L., Dirnhofer, S., Ceriani, L., Zucca, E.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison
Herth, I., Dietrich, S., Benner, A., Hegenbart, U., Rieger, M., Stadtherr, P., Bondong, A., Tran, T.H., Weide, R., Hensel, M., Knauf, W., Franz-Werner, J., Welslau, M., Procaccianti, M., Görner, M., Meissner, J., Luft, T., Schönland, S., Witzens-Harig, M., Zenz, T., Ho, A.D., Dreger, P.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse
Hahn, M, Böttcher, S, Dietrich, S, Hegenbart, U, Rieger, M, Stadtherr, P, Bondong, A, Schulz, R, Ritgen, M, Schmitt, T, Tran, T H, Görner, M, Herth, I, Luft, T, Schönland, S, Witzens-Harig, M, Zenz, T, Kneba, M, Ho, A D, Dreger, P
Published in Bone marrow transplantation (Basingstoke) (01.10.2015)
Published in Bone marrow transplantation (Basingstoke) (01.10.2015)
Get full text
Journal Article
R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY DIAGNOSED HIGH‐RISK BURKITT LYMPHOMA: FINAL RESULTS OF A MULTI‐CENTER RANDOMIZED HOVON/SAKK TRIAL
Chamuleau, M., Stenner, F., Chitu, D., Novak, U., Minnema, M., Visser, O., Stevens, W., Zenz, T., Imhoff, G., Wu, K., Demandt, A., Kersten, M. J., Terpstra, W., Tick, L., Deeren, D., Neste, E., Gregor, M., Veelken, H., Bohmer, L., Casper, C., Dirnhofer, S., Brand, M., Jong, D., Nijland, M., Lugtenburg, P.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
MOLTO, A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CLINICAL TRIAL ON VENETOCLAX, ATEZOLIZUMAB, OBINUTUZUMAB IN RICHTER TRANSFORMATION: SAFETY INTERIM ANALYSIS
Frustaci, A. M., Tedeschi, A., Zinzani, P. L., Pietrasanta, D., Coscia, M., Zenz, T., Motta, M., Gaidano, G., Scarfò, L., Deodato, M., Zamprogna, G., Vitale, C., Cairoli, R., Rossi, D., Montillo, M.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance
Rücker, F G, Russ, A C, Cocciardi, S, Kett, H, Schlenk, R F, Botzenhardt, U, Langer, C, Krauter, J, Fröhling, S, Schlegelberger, B, Ganser, A, Lichter, P, Zenz, T, Döhner, H, Döhner, K, Bullinger, L
Published in Leukemia (01.02.2013)
Published in Leukemia (01.02.2013)
Get full text
Journal Article
P630: TARGETING NEGATIVE REGULATION OF MAPK SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA
Stumpf, M., Ecker, V., Giansanti, P., Lu, J., Zenz, T., Ringshausen, I., Küster, B., Ruland, J., Buchner, M.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article